The use of Matrigel combined with encapsulated cell technology to deliver a complement inhibitor in a mouse model of choroidal neovascularization

PURPOSE: Risk for age-related macular degeneration (AMD), a slowly progressing, complex disease, is tied to an overactive complement system. Efforts are under way to develop an anticomplement-based treatment to be delivered locally or systemically. We developed an alternative pathway (AP) inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Annamalai, Balasubramaniam, Parsons, Nathaniel, Brandon, Carlene, Rohrer, Bärbel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Vision 2020
Materias:
Technical Brief
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245607/
https://www.ncbi.nlm.nih.gov/pubmed/32476817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245607/
https://www.ncbi.nlm.nih.gov/pubmed/32476817

Ejemplares similares